| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/09/2011 | EP2281841A2 Biomarkers for pre-selection of patients for anti-IGF1R therapy |
| 02/09/2011 | EP2281840A2 Inhibition of complement C5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection |
| 02/09/2011 | EP2281839A2 Methods for reducing biofilm formation in infectious bacteria |
| 02/09/2011 | EP2281837A2 Antigen binding domains from fish |
| 02/09/2011 | EP2281836A1 Hybrid proteins from Parietaria judaica major allergens and uses thereof |
| 02/09/2011 | EP2281835A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281834A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281833A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281832A2 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 02/09/2011 | EP2281831A2 Varicella Zoster virus vaccine |
| 02/09/2011 | EP2281830A2 Varicella Zoster virus vaccine |
| 02/09/2011 | EP2281829A2 PCV2 immunogenic compositions and methods of producing such compositions |
| 02/09/2011 | EP2281578A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 02/09/2011 | EP2281575A1 Antibodies for treating cancer |
| 02/09/2011 | EP2281574A1 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same |
| 02/09/2011 | EP2281573A2 Influenza vaccine formulations for intradermal delivery |
| 02/09/2011 | EP2281572A1 West Nile Vaccine |
| 02/09/2011 | EP2281571A2 Outer membrane vesicle (omv) vaccine comprising n. meningitidids serogroup b outer membrane proteins |
| 02/09/2011 | EP2281570A2 Outer membrane vesicle (OMV) vaccine comprising n. meningitidis serogroup B outer membrane proteins |
| 02/09/2011 | EP2281033A1 Post release modification of viral envelopes |
| 02/09/2011 | EP2281007A2 Anti-atheroma vaccine |
| 02/09/2011 | EP2281004A1 Prostate specific membrane antigen antibodies and antigen binding fragments |
| 02/09/2011 | EP2281003A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
| 02/09/2011 | EP2281002A2 Anti-alk1 antibodies and uses thereof |
| 02/09/2011 | EP2281001A1 Anti-areg/hb-egf antibodies and treatment |
| 02/09/2011 | EP2280732A2 Antibodies to granulocyte-macrophage colony-stimulating factor |
| 02/09/2011 | EP2280731A1 Anti human immunodeficiency antibodies and uses thereof |
| 02/09/2011 | EP2280730A2 Method to design and uses of overlapping peptides for monitoring t-cell responses in hiv patients |
| 02/09/2011 | EP2280729A1 Inactivated live-attenuated bluetongue virus vaccine |
| 02/09/2011 | EP2280728A2 Combined measles-human papilloma vaccine |
| 02/09/2011 | EP2280727A1 Vaccine compositions for the treatment of dengue fever and uses thereof |
| 02/09/2011 | EP2280726A1 Anti-viral nutraceutical |
| 02/09/2011 | EP2280725A1 Vaccine for protection against haemophilus parasuis serotype 4 in piglets |
| 02/09/2011 | EP2280724A1 Compositions for treating an inflammatory autoimmune condition |
| 02/09/2011 | EP2280723A1 Zona pellucida binding peptides, expression vectors, compositions, and methods for species-specific immunocontraception of animals |
| 02/09/2011 | EP2280721A1 Indoleamine 2, 3-dioxygenase based immunotherapy |
| 02/09/2011 | EP1765395B1 Anti-gluten egg yolk antibodies for the treatment of celiac disease |
| 02/09/2011 | EP1725659B1 Natural igm antibodies and inhibitors thereof |
| 02/09/2011 | EP1636561B1 Combinatorial protein library screening by periplasmic expression |
| 02/09/2011 | EP1280898B1 Modified es cells and es cell-specific gene |
| 02/09/2011 | EP1181313B1 Peptides for vaccinating against human cmv |
| 02/09/2011 | EP0986577B1 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 02/09/2011 | EP0668777B2 Prostate-specific membrane antigen |
| 02/09/2011 | CN1859926B Polymer encapsulation of adenoviruses |
| 02/09/2011 | CN101970670A Methods for inhibiting angiogenesis using egfl8 antagonists |
| 02/09/2011 | CN101970666A Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof |
| 02/09/2011 | CN101970659A HIV preventive vaccine based on HIV specific antibodies |
| 02/09/2011 | CN101970645A Method for producing vaccinal viral strain of a virus of the reoviridae family |
| 02/09/2011 | CN101970500A Anti-tyrp1 antibodies |
| 02/09/2011 | CN101970499A Monoclonal antibodies for tumor treatment |
| 02/09/2011 | CN101970498A Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof |
| 02/09/2011 | CN101970497A Anti-epcam antibody and uses thereof |
| 02/09/2011 | CN101970494A Humanized anti-c5ar antibodies |
| 02/09/2011 | CN101970493A A monoclonal antibody and a method thereof |
| 02/09/2011 | CN101970492A Fc variants with altered binding to fcrn |
| 02/09/2011 | CN101970488A Humanized antibody molecules specific for il-31 |
| 02/09/2011 | CN101970486A Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf) |
| 02/09/2011 | CN101970485A Heparin-binding epidermal growth factor-like growth factor antigen binding proteins |
| 02/09/2011 | CN101970483A Antibodies against influenza virus and methods of use thereof |
| 02/09/2011 | CN101970478A Modulation of sirpalphalpha - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 02/09/2011 | CN101970468A Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa |
| 02/09/2011 | CN101970464A Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as hbv and hdv entry inhibitors |
| 02/09/2011 | CN101970006A Alpha 5 - beta 1 antibodies and their uses |
| 02/09/2011 | CN101970005A Breaking immunological tolerance with a genetically encoded unnatural amino acid |
| 02/09/2011 | CN101970004A Methods for using and identifying modulators of delta-like 4 |
| 02/09/2011 | CN101970003A Uses of anti-cd40 antibodies |
| 02/09/2011 | CN101970002A Method of inhibiting complement activation with factor bb specific antibodies |
| 02/09/2011 | CN101970001A Cripto结合分子 Cripto binding molecules |
| 02/09/2011 | CN101970000A Prevention and treatment of cerebral amyloid angiopathy |
| 02/09/2011 | CN101969999A Neutralizing monoclonal antibodies against the nogo-66 receptor (ngr) and uses thereof |
| 02/09/2011 | CN101969998A A truncated form of the HIV p17 protein |
| 02/09/2011 | CN101969997A Acute transmitted HIV envelope signatures |
| 02/09/2011 | CN101969996A 多价疫苗 Multivalent vaccine |
| 02/09/2011 | CN101969995A Vaccination with multiple clades of h5 influenza a virus |
| 02/09/2011 | CN101969994A Method of producing japanese encephalitis vaccine stably storable over long time and use of the vaccine |
| 02/09/2011 | CN101969993A Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture |
| 02/09/2011 | CN101969992A Gas57 mutant antigens and gas57 antibodies |
| 02/09/2011 | CN101969991A Malaria vaccine compositions and constituents which elicit cell mediated immunity |
| 02/09/2011 | CN101969990A Compositions and methods of enhancinc immune responses to eimeria |
| 02/09/2011 | CN101969989A Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders |
| 02/09/2011 | CN101969988A Immunotherapy regimes dependent on apoe status |
| 02/09/2011 | CN101969987A Long interspersed nuclear element polypeptide compositions and methods of use thereof |
| 02/09/2011 | CN101969980A Combination of an anti-edb fibronectin antibody-il-2 fusion protein, and a molecule binding to b cells, b cell progenitors and/or their cancerous counterpart |
| 02/09/2011 | CN101969960A Methods of use of gamma inhibitor compounds for the attenuation of pain |
| 02/09/2011 | CN101969947A Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents |
| 02/09/2011 | CN101969929A Powdered protein compositions and methods of making same |
| 02/09/2011 | CN101967466A ORF7 auxotrophic varicella virus strain, vaccine containing same and application thereof |
| 02/09/2011 | CN101967465A Retinol binding protein (RBP) monoclonal antibody and hybridoma cells, preparation method and application thereof |
| 02/09/2011 | CN101967191A Preparation method of HLA-G (Human Leukocyte Antigen G) antibody and application of HLA-G antibody in medicine |
| 02/09/2011 | CN101967190A Method of detecting probnp with a monoclonal antibody binding to the amino acids 38-44 of probnp |
| 02/09/2011 | CN101967186A Encephalitis virus protein and code gene and application thereof |
| 02/09/2011 | CN101967185A Encephalitis virus protein as well as coding gene and application thereof |
| 02/09/2011 | CN101966341A Adenovirus/viruses A replicon chimeric vector hogcholeravaccine and application thereof |
| 02/09/2011 | CN101966338A Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular agonist |
| 02/09/2011 | CN101966337A Genetic products differentially expressed in tumors and the use thereof |
| 02/09/2011 | CN101966336A Recombinant attenuated salmonella typhimurium vector vaccine for expressing CSFV (Classical Swine Fever Virus) immunogenic gene and preparation method thereof |
| 02/09/2011 | CN101966335A Novel HER2/neu gene-modified dendritic cell vaccine |
| 02/09/2011 | CN101280021B Engineered protein VP28-C against shrimp white spot syndrome virus, preparation and use thereof |
| 02/09/2011 | CN101274097B Atomizing grippe vaccine composition and preparation thereof |
| 02/09/2011 | CN101272766B Composition for administration to mammals or humans |